---
schema_version: "secwatch.filing_event.v1"
accession: "0001600620-26-000048"
form_type: "8-K"
ticker: "AUPH"
cik: "0001600620"
company_name: "Aurinia Pharmaceuticals Inc."
filed_at: "2026-05-07T23:59:59+00:00"
generated_at: "2026-05-14T21:44:25.737504+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Aurinia Q1 revenue $77.7M (+24% YoY), EPS $0.25 (+56%); reiterates FY guidance

## Summary
- Net product sales of LUPKYNIS were $73.6M, up 23% YoY.
- Net income of $34.4M, up 48% YoY; diluted EPS $0.25 vs $0.16.
- Cash from operations surged to $32.6M from $1.3M a year ago.
- Repurchased 2.5M shares for $36.2M during Q1.
- Reaffirms 2026 total revenue guidance of $315M–$325M and net product sales of $305M–$315M.

## SEC filing metadata
- accession: 0001600620-26-000048
- form_type: 8-K
- ticker: AUPH
- cik: 0001600620
- company_name: Aurinia Pharmaceuticals Inc.
- filed_at: 2026-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1600620/000160062026000048/0001600620-26-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1600620/000160062026000048/auph-20260507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001600620-26-000048
- JSON: https://secwatch.observer/filing/0001600620-26-000048.json
- Plain text: https://secwatch.observer/filing/0001600620-26-000048.txt

## Source-grounded claims
- claim_id: 016ba43debecfd6b85b9fcc83120501ced0df411
  claim: Aurinia Pharmaceuticals Inc. updated its the three months ended March 31, 2026 guidance (reaffirmed).
  evidence_excerpt: Aurinia Pharmaceuticals Inc. (Aurinia or the Company) issued a press release announcing its financial results for the quarter ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1600620/000160062026000048/0001600620-26-000048-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.